Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

medicine
Written By TheFellowOnCall HemeOncPodcast

Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode!

TheFellowOnCall HemeOncPodcast https://thefellowoncall.com
Sign up to read this post
Join Now
Previous

Episode 077: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - part 1
Next

Episode 075: Intro to CAR-T, Bispecifics (BiTE), and Autologous Transplant